Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Moreland

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Seminars in Arthritis and Rheumatism|June 9, 2018
Arterial lesions in giant cell arteritis: A longitudinal studyTanaz A Kermani, Sehriban Diab, Antoine G Sreih, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Journal of Cellular Immunology|May 14, 2025
Development of a Chikungunya Arthritis Disease Activity Score (CHIK-DAS) Based on a Prospective Cohort StudyAileen Y Chang, Samuel Simmens, Hugh Watson, et al.
Seminars in Arthritis and Rheumatism|February 24, 2004
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learnedPhilip J Clements, James R Seibold, Daniel E Furst, et al.
Arthritis and Rheumatism|November 13, 2002
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trialPaul J DeMarco, Michael H Weisman, James R Seibold, et al.
The Journal of Rheumatology|March 3, 2019
Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic VasculitisGunnar Tomasson, John T Farrar, David Cuthbertson, et al.
Plos One|January 1, 2020
A phenome-wide association study (PheWAS) in the Population Architecture using Genomics and Epidemiology (PAGE) study reveals potential pleiotropy in African AmericansSarah A Pendergrass, Steven Buyske, Janina M Jeff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Plos Genetics|February 6, 2013
Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) NetworkSarah A Pendergrass, Kristin Brown-Gentry, Scott Dudek, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritisJun Inamo, Joshua Keegan, Alec Griffith, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Seminars in Arthritis and Rheumatism|June 9, 2018
Arterial lesions in giant cell arteritis: A longitudinal studyTanaz A Kermani, Sehriban Diab, Antoine G Sreih, et al.
Arthritis and Rheumatism|June 3, 2008
A multicenter, randomized, double-blind, placebo-controlled trial of oral type I collagen treatment in patients with diffuse cutaneous systemic sclerosis: I. oral type I collagen does not improve skin in all patients, but may improve skin in late-phase diseaseArnold E Postlethwaite, Weng Kee Wong, Philip Clements, et al.
Journal of Cellular Immunology|May 14, 2025
Development of a Chikungunya Arthritis Disease Activity Score (CHIK-DAS) Based on a Prospective Cohort StudyAileen Y Chang, Samuel Simmens, Hugh Watson, et al.
Seminars in Arthritis and Rheumatism|February 24, 2004
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learnedPhilip J Clements, James R Seibold, Daniel E Furst, et al.
Arthritis and Rheumatism|November 13, 2002
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trialPaul J DeMarco, Michael H Weisman, James R Seibold, et al.
The Journal of Rheumatology|March 3, 2019
Feasibility and Construct Validation of the Patient Reported Outcomes Measurement Information System in Systemic VasculitisGunnar Tomasson, John T Farrar, David Cuthbertson, et al.
Plos One|January 1, 2020
A phenome-wide association study (PheWAS) in the Population Architecture using Genomics and Epidemiology (PAGE) study reveals potential pleiotropy in African AmericansSarah A Pendergrass, Steven Buyske, Janina M Jeff, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|October 6, 2020
Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2Oskar Schnappauf, Natalia Sampaio Moura, Ivona Aksentijevich, et al.
Plos Genetics|February 6, 2013
Phenome-wide association study (PheWAS) for detection of pleiotropy within the Population Architecture using Genomics and Epidemiology (PAGE) NetworkSarah A Pendergrass, Kristin Brown-Gentry, Scott Dudek, et al.
Biorxiv : the Preprint Server for Biology|July 18, 2023
Deep immunophenotyping reveals circulating activated lymphocytes in individuals at risk for rheumatoid arthritisJun Inamo, Joshua Keegan, Alec Griffith, et al.
Pageof 6